Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Egoal Biotech is a specialized biotechnology company headquartered in Shanghai, China, that focuses on high-throughput single-cell sequencing and spatial multi-omics services. Established in 2015, the company provides a comprehensive technology platform that includes single-cell RNA sequencing, single-cell ATAC-seq, and spatial transcriptomics to support advanced life science research. Egoal Biotech serves a diverse clientele of academic institutions, hospitals, and pharmaceutical companies, offering end-to-end solutions from sample processing to complex bioinformatics analysis. Their expertise is particularly applied in the fields of oncology, immunology, and neurology to help researchers uncover cellular heterogeneity and disease progression mechanisms. The company is recognized for its robust data analysis capabilities and its role in accelerating precision medicine and drug discovery efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Egoal.